Eyenovia Announces FDA Approval of Redwood City as Commercia

Redwood City, California to complement Eyenovia’s facility in Reno, Nevada as well as its contract manufacturer, Coastline International, to produce commercial supply of Mydcombi NEW YORK, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a commercial-stage ophthalmic company, today announced that the company’s facility in Redwood City, California successfully completed FDA inspection for approval as a commercial manufacturing facility. The Redwood City facility will primarily be

Related Keywords

Redwood City , California , United States , Nevada , China , South Korea , Taiwan , Reno , Formosa , Eric Ribner , John Gandolfo , Norbert Lowe , Bren Kern , Michael Rowe , Lifesci Advisors , Eyenovia Inc , Formosa Pharmaceuticals , Coastline International , Exchange Commission , Nasdaq , Chief Executive , Chief Operating , Prescription Drug User Fee Act , Arctic Vision , Eyenovia Corporate Information , Investor Contact , Sci Advisors , Media Contact , Eyenovia , Nc , Product Candidates , Fda ,